Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …

As the rapidly aging population and the rising incidence of end-stage heart failure, extensive
research has been conducted on heart transplantation (HTx). Bibliometrics harbors the …

The twelfth annual report from The Society of Thoracic Surgeons (STS) Interagency Registry
for Mechanically Assisted Circulatory Support (Intermacs) highlights outcomes for 26 688 …

Importance Previous studies have described the secular trends of overall heart failure (HF)
hospitalizations, but the literature describing the national trends of unique index …

TaggedPIn 2013, the International Society for Heart and Lung Transplantation (ISHLT)
published the first official guidelines for implantable mechanical circulatory support (MCS) …

Abstract Background In the MOMENTUM 3 (Multicenter Study of MagLev Technology in
Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3) pivotal trial …

Background & Aims Patients with inflammatory bowel diseases (IBDs) have a high risk of
venous thromboembolism (VTE). We assessed the timing and risk factors associated with …

Background: Gastrointestinal bleeding (GIB) is a leading cause of morbidity during
continuous-flow left ventricular assist device (CF-LVAD) support. GIB risk assessment could …

Objective To determine the impact of socioeconomic status using median household income
within the patient's community on rate of readmission among patients with heart failure (HF) …

Introduction The treatment options for advanced heart failure patients drastically changed
with the introduction of left ventricular assist devices (LVADs), either as bridge to transplant …